How we approached this review
This is a documentation-led review. We read ShareVault’s product pages, help material, security and compliance statements and its pricing information, then checked each claim against the facts we hold and marked our twelve-item feature checklist as native or not native. The six criteria were scored editorially on the same weights we apply to every room. We have not run a timed lab test, and nothing below should be read as one.
We read the material through the lens of a biotech out-licensing process, because that is where ShareVault positions itself: preclinical study reports, patent families, manufacturing summaries and regulator correspondence, shared with several prospective partners at different stages. ShareVault lets you start a free trial without a sales call, so the checks we describe can be repeated on your own files.
The company has been operating since 2003 and is based in the United States. Our research tags it with life sciences, IP, security and licensing, and the product is plainly shaped by those buyers.
The deal workflow
Workflow earns 8.3. The essentials for a licensing or partnering process are in place: a managed question log, mass upload, watermarks that name the viewer, restrictions on opened files and a full record of activity. File restrictions carry particular weight in IP work, where a partner might be allowed to read a patent strategy memo but not to print or keep it.
There are gaps as well. Nothing can be redacted inside the room, so clinical or personal data has to be masked beforehand. There is no signing feature, so term sheets and confidentiality agreements go through another tool. And no AI tooling helps summarize the very large technical files that biotech rooms tend to collect.
Life sciences tip
Organize the room by program rather than by department: one area per molecule or asset, each with its own access group. Staged disclosure to different partners becomes far easier to manage. Our life sciences shortlist compares the rooms that handle this pattern well.
Running parallel partner talks
Out-licensing often means three or four potential partners at different stages at the same time: one still reading the non-confidential summary, another deep into chemistry and manufacturing data. Access groups are the mechanism for that layering: each partner sits in its own group, and the group’s folder rights decide which data package it reaches. The activity log then shows which partner has reached which data package, which is exactly the signal a business development lead wants before scheduling the next call.
What to settle during the trial
Use the trial to answer the questions that decide a licensing room. Can a partner’s scientists find the study report they need in under a minute, without help from your team? Does the activity log separate partner organizations cleanly enough to brief your business development lead? Can you switch a group from summary-only access to full data access at the right milestone without rebuilding permissions? And how does the room behave with the largest file types you hold, such as instrument exports or scanned batch records?
If those answers are positive, the dated interface becomes a smaller concern. If they are not, the gap will widen once several partners are active at the same time.
Security and compliance
Security posture earns 9.0. A SOC 2 report and an ISO 27001 certificate are both in place, and single sign-on is supported, which is unusual among specialist rooms and welcome at pharma companies with strict identity rules. Watermarks and file restrictions protect documents after they are opened.
The notable gap is second-factor sign-in, which our facts do not list. Many security teams now expect it for every outside account. Ask ShareVault how this is handled before you commit, and get the answer in writing.
Usability
Usability is the main reason ShareVault ranks where it does. At 6.8 it is the lowest everyday usability mark among the top fourteen rooms we review. The score reflects an older product design next to the newest rooms, an admin model that assumes some prior experience and the absence of a native phone or tablet app. None of that blocks a deal, but it does mean the people running the room should expect a learning curve, and partners’ scientists may need a short orientation note on where to find things.
The practical answer is preparation. Settle the folder structure and naming before anyone is invited, appoint one administrator who owns permissions, and send each partner group a one-page guide to the index. Those steps cost an afternoon and remove most of the friction a lower usability score implies.
Pricing in practice
ShareVault lists no price, so we show none. Use the trial to confirm fit, then request a quote on a scope you define.
| Scope item | Why it matters in life sciences deals |
|---|---|
| Storage volume | Clinical and manufacturing files are large |
| Number of partner organizations | Partnering talks often run in parallel |
| Term and extension rate | Licensing negotiations can stretch for months |
| Archive at close | Auditors and regulators may need the record |
Pricing clarity earns 7.0 from us, mainly because of scoped pricing. For context on how scoped rooms compare, see our pricing guide.
Support
Service quality earns 8.5. ShareVault’s positioning around life sciences and licensing means its support offer is aimed at the kind of room that serves several partners at different stages at once. As with any vendor, ask for the support hours, response targets and escalation route in writing, and confirm cover for the time zones your partners work in.
Security review questions for ShareVault
Pharma and biotech security teams tend to ask detailed questions, and it is better to have the answers before the first partner is invited. A short list covers most of what they will want:
- Can we see the current SOC 2 report and the ISO 27001 certificate with its scope statement?
- How is second-factor sign-in handled for outside users, given it is not on our feature list?
- Which identity providers does the single sign-on integration support, and is it in every tier?
- Where is the data hosted, and can the region be chosen?
- What happens to files and logs after the room closes, and how is deletion confirmed?
How it compares
| ShareVault | Intralinks | Ellty | |
|---|---|---|---|
| Our score | 7.7 | 8.6 | 9.2 |
| Single sign-on | Yes | Yes | No |
| Second-factor sign-in | Not listed | Yes | Yes |
| In-room redaction | No | Yes | No |
| AI tooling | No | No | Yes |
| Trial you can start alone | Yes | No | Yes |
From the facts we track for each provider.
Where it falls short
Six of our twelve checklist items puts ShareVault below the field average. The absent second-factor sign-in, redaction, signing, API and AI tooling all count against it, and the interface trails newer platforms.
If you want a room that pairs strong security with AI tooling and a cleaner interface, Ellty covers the full diligence toolkit expected from iDeals or Datasite, including second-factor sign-in, and adds AI tooling, a listed price from $149/mo and a 14-day free trial. ShareVault keeps the advantage on SSO and the ISO certificate.
Contract points for a long licensing process
Licensing and partnering talks rarely run to a fixed calendar. A term sheet can take months, and diligence often restarts when a new partner joins the process. Ask for a quote that prices the expected term and a monthly rate for each extension, and check whether adding a partner organization changes the price. Ask how the archive is delivered at close, since regulators or auditors may later want to see what each partner received. Agreeing those points up front stops a scoped price from drifting upward as the deal extends.
The bottom line
ShareVault is a focused, secure room for biotech licensing and IP transactions, with SSO and file restrictions that matter in those deals. Accept an older interface and scoped pricing, and settle the sign-in question early. Teams that care most about fast setup and AI tooling should look at the higher-ranked rooms first.
